Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

Adding atezolizumab and bevacizumab to TACE can improve outcomes in previously untreated, unresectable HCC, data suggest.

Dr. Chen echoes the American Heart Association's recommendation for daily salt intake, which is 2,300 mg per day. However, Dr ...

Some studies show that people with white coat hypertension may have more organ damage or a higher risk of future health problems compared to those with normal blood pressure all the time. Even ...